pharmaphorum

APRIL 30, 2021

Blogger Chris Aldred and Joe Delahunty from Ascensia discuss what the industry often gets wrong in its patient engagement. • Read the latest issue Deep Dive: Market Access 2021 in full. Subscribe to future issues of Deep Dive. The post Deep Dive: Market Access appeared first on.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

STAT

JUNE 21, 2023

Elle Brooks-Tao, a filmmaker, got thrust into the confusing world of Lyme disease when a family member became infected and had debilitating symptoms for over eight years before being diagnosed. The reported cases of tick-borne illnesses like Lyme in the U.S. had risen “to a scary degree” she said.

267

267

pharmaphorum

JULY 7, 2022

Read Deep Dive: Oncology in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

MAY 6, 2022

Read Deep Dive: Market Access in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 2, 2022

Read Deep Dive: Digital Health 2022 in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Communication 52

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 13, 2021

Manage the publication and production of Deep Dive magazine (content planning, commissioning, editing, interviewing, writing, managing advertisers and review process). Planning and organising features and Deep Dive content. Producing articles, Deep Dive. The post Editor (Deep Dive) appeared first on.

People Management 52

People Management Communication 52

pharmaphorum

SEPTEMBER 22, 2022

Read Deep Dive: Communications & Commercialisation 2022 in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 14, 2020

As this issue’s title suggests, patient centricity is about more than just talking points and marketing strategies – it requires companies to truly listen to, engage with and partner with the patients they serve, and in putting this month’s Deep Dive together it’s been great to see that so many pharma firms are now taking this to heart.

Pharmaceutical Companies 76

Pharmaceutical Companies Pharmaceutical Companies 76

pharmaphorum

FEBRUARY 24, 2022

Read Deep Dive: Research and Development in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharma and Life Sciences Blog

OCTOBER 19, 2023

Harnessing Procurement Power: A Deep Dive into Managing Scope 3 Emissions priyanka.katke… Thu, 10/19/2023 - 23:06 Scope 3 emissions present one of the most complex challenges for organizations — one that no forward-thinking company can ignore. To navigate this maze successfully, enterprises have to work closely with their suppliers.

52

52

pharmaphorum

OCTOBER 28, 2021

Read Deep Dive: Patients and Partnerships in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

pharmaphorum

OCTOBER 1, 2021

Read Deep Dive: Communications and Commercialisation in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

pharmaphorum

FEBRUARY 26, 2021

From animal processing, to cell therapy and AI, Tim Mullane, president, and chief operating officer tells pharmaphorum how FUJIFILM Irvine Scientific has evolved to become one of the top manufacturers of cell culture media. • Read the latest issue Deep Dive: Research and Development 2021 in full.

Vaccines 59

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

JUNE 30, 2021

Read Deep Dive: Oncology 2021 in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

SEPTEMBER 17, 2020

Patient simulations have been a key tool for educating physicians for decades – and now cutting-edge tech is helping them become more impactful than ever. • Read the latest issue Deep Dive: Communications 2020 in full. Subscribe to future issues of Deep Dive. The post Deep Dive: Communications 2020 appeared first on.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

PharmExec

JULY 31, 2023

In this video, we dive deep into the expanded use of registries as external control arms in clinical trials. While clinical registries are a valued source of longitudinal, real-world data, registries also provide expanded options for research and advancing randomized clinical trials.

52

52

pharmaphorum

NOVEMBER 2, 2020

Most of the digital health experts we spoke to for this issue of Deep Dive made one thing clear – no one can really say what the future holds for digital tech in the pharma and healthcare industries. Subscribe to future issues of Deep Dive. The post Deep Dive: Digital Health Innovation 2020 appeared first on.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

MARCH 1, 2024

Gain insights into the research and development strategies of leading companies like Alexion, Samsung Biologics, JPM, UCB, and Clinigen with in-depth interviews and analysis for 2024.

52

52

PharmaVoice

JULY 18, 2022

Learn about Digital Opinion Leaders who curate tailored content experiences and provide value to their followers.

130

130

Commonwealth Pharmacists Association

JUNE 22, 2023

A Deep Dive into the Commonwealth Health Ministers Meeting and the World Health Assembly 2023 The annual Commonwealth Health Ministers Meeting (CHMM23) was held in Geneva on 20th May 2023, the weekend before the 76th World Health Assembly (WHA76).

52

52

European Pharmaceutical Review

SEPTEMBER 2, 2022

The post Pharmacovigilance deep dive: risk minimisation measures appeared first on European Pharmaceutical Review. Patient-Focused Drug Development: Collecting Comprehensive and Representative Input Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; June 2020. Available from: [link].

Adverse Reactions 73

Adverse Reactions Documentation Medical Schools Packaging 73

STAT

MAY 23, 2023

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.    Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.    What we know so far about generative AI in health Read the rest…

Hospitals 180

Hospitals 180

Pharmaceutical Commerce

JUNE 1, 2023

While generics and adherence challenges are keeping drugmakers up at night, breakthroughs in the pipeline coupled with innovative uses of artificial intelligence and machine learning techniques are bringing optimism to the cardiovascular disease space.

70

70

STAT

DECEMBER 19, 2023

Another thing: Join STAT’s Adam Feuerstein and a panel of experts today for a deep-dive discussion into  precision cancer medicines. Today, a hospital in Barcelona goes rogue with its own CAR-T treatments, we learn more about Wegovy’s anti-inflammatory mechanisms, and more. Read the rest…

Hospitals 223

Hospitals Drug Pricing Drug Development 223

EMCrit Project

NOVEMBER 18, 2022

Lumbar Puncture This seemingly simple procedure seems to be the Achilles's heel or many resus docs! If you have a good baseline knowledge of how to do the lumbar puncture correctly, it is super easy. If you have bad habits, then you will make your poor patient look like a pin cushion. EMCrit Project by Scott Weingart, MD FCCM.

81

81

STAT

NOVEMBER 17, 2023

Damian here with a deep dive on a historic moment for genome editing, mixology tips from a biotech lifer, and a look at why scientists are interested in muscle-building drugs. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone.

Drug Pricing 170

Drug Pricing Drug Development 170

Outsourcing Pharma

SEPTEMBER 13, 2023

In the rapidly evolving world of pharmaceutical development, high-potency active pharmaceutical ingredients (HPAPIs) are becoming powerful tools.

86

86

STAT

JANUARY 18, 2023

On Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology. This column is adapted from the new STAT Report : Targeting cancer: the new frontier of immunotherapy and precision oncology.

269

269

pharmaphorum

APRIL 4, 2024

On today’s podcast, he chats with guest host and Deep Dive editor Eloise McLellan about his biggest takeaways from the two-day event. Last week, pharmaphorum editor-in-chief Jonah Comstock travelled to Philadelphia for Reuters Pharma USA.

112

112

STAT

JANUARY 20, 2023

On Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology. This column is adapted from a new STAT report , “Targeting cancer: the new frontier of immunotherapy and precision oncology.”

220

220

Outsourcing Pharma

OCTOBER 6, 2023

EDETEK and Pfizer are in collaboration to speed access to clinical data, promote interoperability and enable data visualization to drive faster decision-making capabilities in clinical operations.

86

86

STAT

APRIL 6, 2023

Our colleague Matthew Herper joins us for a deep dive into Illumina, explaining how the biggest company in genome sequencing lost the faith of shareholders and painted itself into a corner. And can you ever really go home again? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

197

197

PharmaTech

APRIL 20, 2023

Gregor Kawaletz, head of Oral Solid Dose Business Unit at Recipharm, discusses the immediate future of oral biologics

52

52

Outsourcing Pharma

OCTOBER 5, 2023

At DPharm 2023, there was a huge meeting of minds to discuss the latest innovations in clinical trials.

59

59

STAT

AUGUST 30, 2023

On Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology. K RAS, one of the most common genetic mutations in cancer, has been one of the most tantalizing oncogenic targets for drug developers since its discovery four decades ago.

Drug Development 220

Drug Development 220

The Script

OCTOBER 26, 2023

Our team at Rx relief dives deep into the career.

Pharmacy Technician 98

Pharmacy Technician 98

Pharmaceutical Commerce

MARCH 19, 2024

Panel discusses PAN Foundation’s inaugural “State of Patient Access” report, and dives deep into patient challenges.

52

52